|
Video: What is a Stock Split?
|
|
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. Co.'s collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. According to our Ligand Pharmaceuticals stock split history records, Ligand Pharmaceuticals has had 1 split. | |
|
Ligand Pharmaceuticals (LGND) has 1 split in our Ligand Pharmaceuticals stock split history database. The split for LGND took place on November 02, 2022. This was a 1603 for 1000 split, meaning for each 1000 shares of LGND owned pre-split, the shareholder now owned 1603 shares. For example, a 1000 share position pre-split, became a 1603 share position following the split.
When a company such as Ligand Pharmaceuticals splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the Ligand Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1603 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ligand Pharmaceuticals shares, starting with a $10,000 purchase of LGND, presented on a split-history-adjusted basis factoring in the complete Ligand Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$41.97 |
|
End price/share: |
$71.27 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
69.81% |
|
Average Annual Total Return: |
5.44% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$16,982.08 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
11/02/2022 | 1603 for 1000 |
|
|